Short Sellers Pull Back from Sabra Health Care REIT Ahead of Q3 Print

Short sellers have been cutting positions in SBRA at an unusually fast pace. Short interest has fallen roughly 11% over the past week to 17.7 million shares, equivalent to 7.1% of the free float. That weekly decline is about 1.8 standard deviations steeper than the typical move for this stock over the past year, making it one of the more decisive retreats from a short position seen in recent months.

The lending market confirms there is no pressure driving that exit. Availability has widened to 522%, meaning roughly five shares are available to borrow for every one already lent out, comfortably above the 52-week tightest reading of 249%. Borrowing costs remain negligible at 0.40%, little changed on the week. With that much room in the pool, shorts are leaving voluntarily rather than being squeezed out. Over the same period, the stock itself barely moved, down 0.3% on the week to $19.72, underperforming the median of its closest peers, which edged up around 0.5%.

The options market adds a mild note of caution. The put/call ratio has drifted to 0.77, above its 20-day average of 0.70, but only about 0.8 standard deviations from the mean and well inside its 52-week range of 0.15 to 0.90. That is a modest tilt toward protection rather than any strong directional signal.

Analysts heading into the print have been trimming targets without abandoning their ratings. Wells Fargo cut its target from $23 to $21 in mid-October while holding its Overweight rating; UBS and Barclays both made similar reductions, each keeping neutral-equivalent stances. The consensus target sits at $22.36 against a current price of $19.72, implying around 13% upside on the Street's collective view. The debate turns on whether improving senior housing occupancy and the Avamere re-tenanting, struck at roughly 30% above prior cash rent, can overcome continued reimbursement pressure and the $9 million increase in full-year G&A guidance. A large loan receivable maturing this year is also on the bear side's checklist.

The print will test whether the operational progress on re-tenanting and balance-sheet reduction, net debt-to-EBITDA reported at 4.8x, is translating into the normalized AFFO trajectory that has kept most analysts from cutting their ratings even as their targets came in.